Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The endothelial glycocalyx as a potential modifier of the hemolytic uremic syndrome.

European journal of internal medicine - 1 Sept 2013

Boels Margien G S, Lee Dae Hyun, van den Berg Bernard M, Dane Martijn J C, van der Vlag Johan, Rabelink Ton J

Abstract excerpt

Atypical hemolytic uremic syndrome (HUS) is a renal disease due to complement dysregulation. Many of the known causes of atypical HUS originate from genetic mutations of complement regulatory proteins, such as complement factor H (CFH) and thrombomodulin. However, atypical HUS has only a genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atypical Hemolytic Uremic Syndrome
Share to Complement Activation
Share to Complement Factor H

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endothelium, Vascular

Share to Genetic Predisposition to Disease

Share to Hemolytic-Uremic Syndrome

Share to Heparan Sulfate Proteoglycans

Share to Thrombomodulin

Source

Identifiers

PMID: 23357408
DOI: 10.1016/j.ejim.2012.12.016

Genes

CFH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23357408-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The endothelial glycocalyx as a potential modifier of the hemolytic uremic syndrome.PMID 23357408Read ↗

Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.Semantic proximity Read ↗

The genetics of atypical hemolytic uremic syndromeSemantic proximity Read ↗

Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome.Semantic proximity Read ↗

Update on evaluating complement in hemolytic uremic syndrome.Semantic proximity Read ↗

Complement mutations in diacylglycerol kinase-ε-associated atypical hemolytic uremic syndrome.Semantic proximity Read ↗

Alternative complement pathway assessment in patients with atypical HUS.Semantic proximity Read ↗

Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.Semantic proximity Read ↗

Genetics of atypical hemolytic uremic syndrome (aHUS).Semantic proximity Read ↗

Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome.Semantic proximity Read ↗

IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic SyndromeSemantic proximity Read ↗

Genetics and complement in atypical HUS.Semantic proximity Read ↗

Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 GlomerulopathiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.